Methylphenidate For Obesity & Weight Loss

Methylphenidate treatment can be a benefit for obesity disorder in men, women and children due to its side effect of hunger suppression which can cause those with moderate or severe obesity not to feel hungry while the medication is in effect.

Benefits For Overweight Individuals

The trade names of the drugs used to treat obesity disorder in men, women and children include Concerta, Methylphenidate, Ritalin, Ritalin SR, Ritalin LA, Metadate CD, Metadate ER, Methalyn and Methalin ER.

Dopamine transporter inhibitors like methylphenidate increases heart rate, metabolic rate and decreases and suppresses hunger allowing those dangerously overweight a chance to lower their body mass index and gain control of their diet if used in conjunction with a healthy diet plan and exorcise.

Anorexia Risk From Hunger Suppression & Diet

Due to the fact that methylphenidate and other related medications cause decreased hunger, there is a risk of the hunger suppression causing a person suffering from obesity disorder to aqcuire an unhealthy diet, or eratic eating habits.

This risk of developing anorexia is serious and must be carefully weighed before deciding to take methylphenidate or similar drugs for obesity disorder. It is important to undertake this kind of treatment only under a doctors supervision with a proper diet and eating plan in place.

Danger With Heart Conditions

Methylphenidate and other similar medications can cause serious issues with those who have existing heart conditions due to the increase in heart rate and metabolism.

Anyone with any type of heart conditions should talk to their doctor before beginning methylphenidate treatment for obesity disorder due to the risk of stroke, heart attack or other types of heart or cardiovascular complications.

*NOTE* Using methylphenidate, meth, methamphetamine or any psychostimulant medications can cause serious health problems, including death. Use under doctor supervision only!

Leave a Reply

Your email address will not be published. Required fields are marked *